Pharma company Sandoz named in US price-fixing lawsuit
Sandoz split from Novartis in 2003 and now has annual sales in excess of $10 billion.
Keystone / Martin Ruetschi
The Germany-based subsidiary of Swiss pharmaceutical giant Novartis is one of 20 companies in the United States targeted in a 44-state class action suit for breaching rules on fair competition.
This content was published on
1 minute
SDA-Keystone/ac
The names of the companies were revealed on SundayExternal link by Connecticut Attorney General William Tong. The lawsuit accuses the companies of inflating the prices of more than 100 different drugs.
“Sandoz’s name appears in a court case, which concerns virtually the entire pharmaceutical generics industry,” Novartis told the Swiss news agency AWP. According to the Basel-based parent company, the accusations are unfounded and will be contested vigorously.
The American prosecutor mentioned that “Teva, Sandoz, Mylan, Pfizer and 16 other generic producers” are accused of conspiring among themselves to set prices, allocate markets and distort offers of more than 100 generic products. In some cases, the price of some substances increased more than tenfold. In addition to Sandoz, a former vice president at the company, Armando Kellum, was named as an individual defendant in the case.
“We have hard evidence that shows the generic drug industry perpetrated a multi-billion-dollar fraud on the American people,” said Tong. “We have emails, text messages, telephone records, and former company insiders that we believe will prove a multi-year conspiracy to fix prices and divide market share for huge numbers of generic drugs.
Popular Stories
More
Culture
Documentary portrays Swiss teenagers forced to return to parents’ homeland
Switzerland condemned for deciding to deport gay Iranian
This content was published on
Switzerland violated the prohibition on inhuman treatment by considering that a gay Iranian could be returned to his country.
Gestational diabetes found to increase risk of adult-onset diabetes
This content was published on
A research team from the Lake Geneva region has identified persistent dysfunctions in glucose regulation in women with gestational diabetes. In the long term, this can increase the risk of adult-onset diabetes by up to ten times.
Swiss village must be evacuated by midday on Sunday
This content was published on
The village of Brienz-Brinzauls in eastern Switzerland, which is threatened by a rockfall, must be evacuated by 1pm on Sunday. All residents must leave the village.
This content was published on
A former judge of the Graubünden Administrative Court in eastern Switzerland has been found guilty of rape, sexual harassment and threatening a former trainee.
Costs and care time increase in Swiss retirement and nursing homes
This content was published on
In 2023 the costs of retirement and nursing homes increased by 5% compared to 2022 and those of assistance and care at home by 7%. Together, they amounted to CHF15 billion.
This content was published on
Almost half of the population in Switzerland shows clear to pronounced signs of smartphone addiction, according to a survey.
Swiss healthcare stakeholders want to save CHF300 million
This content was published on
The main players in the Swiss healthcare sector want to save around CHF300 million ($340 million) in healthcare costs a year from 2026.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.